XtalPi Inc, a Chinese pharmaceutical firm that uses artificial intelligence (AI) to accelerate the development of new drugs, announced on Monday that it has garnered $318.8 million in a Series C round of financing.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
